<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>International Journal of Radiation Research</title>
<title_fa>نشریه پرتو پژوه</title_fa>
<short_title>Int J Radiat Res</short_title>
<subject>Basic Sciences</subject>
<web_url>http://ijrr.com</web_url>
<journal_hbi_system_id>79</journal_hbi_system_id>
<journal_hbi_system_user>journal79</journal_hbi_system_user>
<journal_id_issn>2322-3243</journal_id_issn>
<journal_id_issn_online>2345-4229</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/ijrr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1399</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2020</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<volume>18</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Effect of dose grid resolution on the results of patient-specific quality assurance for intensity-modulated radiation therapy and volumetric modulated arc therapy</title>
	<subject_fa>Medical Physics</subject_fa>
	<subject>Medical Physics</subject>
	<content_type_fa>تحقيق بديع</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;Background: This study aims to investigate the effect of reference dose calculation grid size (RDCGS) on gamma passing rate (GPR) for patient-specific quality assurance of intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT). Materials and Methods: A total of 20 patients were retrospectively selected. Both IMRT and VMAT plans were generated for each patient. Reference dose distributions for gamma analysis were calculated with RDCGS of 1&amp;ndash;5 mm at intervals of 1 mm. Dose distributions were measured using MapCHECK2 and ArcCHECK dosimeters. Both global and local gamma analyses with gamma criteria of 3%/3 mm, 2%/3 mm, 2%/2 mm, and 2%/1 mm were performed with various RDCGS. Results: As the RDCGS increased from 1 mm to 5 mm, the average global GPRs with 2%/2 mm for VMAT with MapCHECK2 and ArcCHECK decreased by 9.3% and 5.9%, respectively. The average local GPRs decreased by 14% and 11.7%, respectively. For IMRT, the global GPRs decreased by 4.8% and 6%, respectively, whereas the local GPRs decreased by 10.5% and 8.6%, respectively. The effect of the RDCGS on the GPRs became larger when performing local gamma analysis as well as when applying small distance-to-agreement (DTA). As the RDCGS increased, the average changes in the GPR per mm of DTA change increased regardless of the type of radiotherapy, detector, or gamma analysis. Conclusion: For an accurate verification of the IMRT and VMAT plans, it is recommended that the reference dose distribution must be calculated with the smallest possible RDCGS.&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Dose calculation grid, gamma analysis, intensity-modulated radiation therapy, patient-specific QA, volumetric modulated arc therapy.</keyword>
	<start_page>521</start_page>
	<end_page>530</end_page>
	<web_url>http://ijrr.com/browse.php?a_code=A-10-2055-39&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>M. </first_name>
	<middle_name></middle_name>
	<last_name>Chun</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460016017</code>
	<orcid>7900319475328460016017</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>J.I. </first_name>
	<middle_name></middle_name>
	<last_name>Kim</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460016018</code>
	<orcid>7900319475328460016018</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>D.H. </first_name>
	<middle_name></middle_name>
	<last_name>Oh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460016019</code>
	<orcid>7900319475328460016019</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, Chung-Ang University Hospital, Seoul, Republic of Korea;</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>H.G. </first_name>
	<middle_name></middle_name>
	<last_name>Wu</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460016020</code>
	<orcid>7900319475328460016020</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>J.M.</first_name>
	<middle_name></middle_name>
	<last_name>Park</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>leodavinci@naver.com </email>
	<code>7900319475328460016021</code>
	<orcid>7900319475328460016021</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
